Response to Rajendra.

[1]  S. Rajendra.  Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. , 2022, The American journal of gastroenterology.

[2]  N. Shaheen,et al.  Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline , 2022, The American journal of gastroenterology.

[3]  N. Merrett,et al.  Human papillomavirus infection in esophageal squamous cell carcinoma and esophageal adenocarcinoma: a concise review , 2020, Annals of the New York Academy of Sciences.

[4]  V. Konda,et al.  Aberrant p53 Immunostaining in Barrett’s Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses , 2019, Digestive Diseases and Sciences.

[5]  G. Falk,et al.  Clinical Guidelines Update on the Diagnosis and Management of Barrett’s Esophagus , 2018, Digestive diseases and sciences.

[6]  C. Hassan,et al.  Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement , 2017, Endoscopy.

[7]  J. Emery,et al.  Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma , 2015, Journal of gastroenterology and hepatology.

[8]  Rebecca C Fitzgerald,et al.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus , 2013, Gut.

[9]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.